Business Wire

Masimo Announces FDA 510(k) Clearance of O3™ Regional Oximetry for Pediatric Patients

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ:MASI) announced today FDA 510(k) clearance for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also ...
The Globe and Mail

Masimo’s Pediatric SpO2 Study With Philips Monitors: What Investors Should Watch

Masimo Corp. is sponsoring a new clinical study titled “Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations.” The goal is to confirm ...
EDN

Finger Heart Rate and Pulse Oximeter Smart Sensor with Digital Signal Processing

The MAXREFDES220# reference design provides everything you need to quickly prototype your product to measure finger-based heart rate and blood oxygen saturation level (SpO2). The MAXREFDES220# ...
Pharmabiz

Study investigates accuracy of respiration rate obtained from pulse Rad-G pulse oximetry on pediatric patients using Masimo RRp

Masimo, a global medical technology company, announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp on ...